Global B2B expansion Chanelle Pharma positions itself as a global end-to-end partner with operations in Ireland, the UK, Portugal, and Jordan and a footprint in over 90 countries. Sales opportunities exist in expanding contract manufacturing and private label collaborations for human and animal health products across new regional markets.

Animal and Human Health The company emphasizes both human and animal health, including a dedicated Head of Animal Health. This dual focus opens cross-segment sales potential for integrated solutions, custom formulations, and bundled services across pharmaceuticals and animal health product lines.

Digital Transformation Recent moves toward SAP Cloud ERP Private and partnerships to modernize manufacturing indicate a readiness to adopt scalable, compliant manufacturing and supply chain solutions. This suggests opportunities for selling advanced ERP, analytics, and integration services to streamline operations.

Leadership and Growth New CFO appointment and strategic leadership hires signal an emphasis on financial discipline and growth investments. Targeted pitches around cost-efficient manufacturing, export-ready capabilities, and high-growth product categories could resonate with the executive team.

Strategic Partnerships Highlighted by partnerships and a global, differentiated value proposition, Chanelle Pharma seeks meaningful collaborations to accelerate scale. Propose co-development, distribution, or regional manufacturing partnerships to extend market reach and portfolio diversification.